lysergic acid diethylamide has been researched along with Hypochondriacal Neuroses in 1 studies
Lysergic Acid Diethylamide: Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.
lysergic acid diethylamide : An ergoline alkaloid arising from formal condensation of lysergic acid with diethylamine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Monosymptomatic hypochondriasis, including delusional parasitosis and non-neurotic dysmorphophobia, are disorders which have been observed and recorded over the past century." | 2.38 | Hypothesis: involvement of the serotonergic system in the clinical expression of monosymptomatic hypochondriasis. ( King, BH, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| King, BH | 1 |
1 review available for lysergic acid diethylamide and Hypochondriacal Neuroses
| Article | Year |
|---|---|
Hypothesis: involvement of the serotonergic system in the clinical expression of monosymptomatic hypochondriasis.
Topics: Humans; Hypochondriasis; Lysergic Acid Diethylamide; Receptors, Serotonin; Serotonin | 1990 |